Pre-specified Events to Trigger Interim Analysis of Phase 3 REGAL Study in Patients with Acute Myeloid Leukemia (AML) Remains on Track for Q4 2024 – – Data from the Phase 2a Trial of SLS009 in ...

Live webcasts of the presentations will be available on the Events & News – Events page of Jasper's Investor Relations website. An archived replay of each presentation will be available on Jasper's ...

(Courtesy of Texas Children's Hospital) At Texas Children's Hospital, Fivecoat's daughter Shelly McAfee and her husband Tyler ...

Veteran NBA referee Scott Wall was diagnosed with acute myeloid leukemia earlier this year, the National Basketball Referees ...

In August, Syros discontinued enrollment in the Phase II SELECT-AML-1 trial, in which it was evaluating a triplet regimen of tamibarotene with venetoclax and azacitidine in newly diagnosed, unfit ...

NBA referee Scott Wall was diagnosed with acute myeloid leukemia earlier this year and is in treatment, the National ...

Hematopoietic stem cell transplant (HSCT) after first complete remission appears more effective than non-HSCT consolidation in older patients with AML.

San Francisco–based Ossium Health has carried out three transplants for cancer patients using stem cells from deceased donors ...

I was diagnosed with acute myeloid leukemia, and the prognosis was not good. I was given just a few months to live. The only ...

The response rate in the control cohort is in line with historical data on azacitidine. Investors, already burnt by setbacks ...

" I’m honored to join Innate Pharma at such a pivotal moment in its evolution,”said Jonathan Dickinson, Chief Executive Officer of Innate Pharma. “ We achieved notable regul ...

Caroline Coughlin is first and presenting author. Correlation of Baseline Gene Mutations With Quizartinib Efficacy in ...